Joint Q3 revenue misses analyst expectations
Joint Q3 revenue misses analyst expectations
Overview
Chiropractic clinic franchisor's Q3 revenue rose 1% yr/yr but missed analyst expectations
Net income from continuing operations increased to $1.5 mln from $290,000 a year ago
Company repurchased $3.8 mln in stock and authorized an additional $5 mln buyback
Outlook
Joint now sees 2026 system-wide sales between $508 mln and $512 mln, down from $519 mln-$552 mln
Joint maintains 2026 consolidated adjusted EBITDA guidance at $12.5 mln to $13.5 mln
Result Drivers
MEMBERSHIP GROWTH OFFSET - Co said higher active membership and lifetime value per member were partially offset by lower average patient spend and fewer new patients, citing macroeconomic challenges
RD ROYALTY REDUCTION - Lower cost of revenues attributed to reduced regional developer royalty costs from reacquired territories
OPERATING DISCIPLINE - General and administrative expenses fell due to cost controls and a leaner structure after refranchising
Company press release: ID:nGNX5F99Zy
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Miss | $13.6 mln | $14.85 mln (4 Analysts) |
Q3 Loss Per Share |
| $0.01 |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Joint Corp is $9.00, about 19.8% above its November 4 closing price of $7.51
The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 28 three months ago
Reuters Recommended Reads
Nov 4 - Dutch Bros Q3 revenue slightly beats estimates after new shop openings
Nov 4 - Applebee's owner Dine Brands beats Q3 sales estimates on value, menu innovation
Nov 5 - Planet Fitness Q3 revenue rises 9%, beats estimates
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Joint
See all newsJoint Corp reports results for the quarter ended September 30 - Earnings Summary
Joint Q3 revenue misses analyst expectations
Brief: Joint Q3 EPS USD -0.01
Brief: Joint Corp To Reacquire Texas Regional Development Rights And Terminate Related Agreements
Brief: Joint Corp. To Close Underperforming Clinics In 2026